About Index Trending news
Analyze
Pricing
Selecta Biosciences

Selecta Biosciences

Work at Selecta Biosciences? Add yourself to this profile

Selecta Biosciences

Selecta Biosciences, a biopharmaceutical company, develops nanoparticle immunomodulatory drugs for the treatment and prevention of diseases.
Edit Profile
More info

Elsewhere

Companies in the same industry

Neurelis Neurelis Vanda Pharmaceuticals Vanda Pharmaceuticals HemoGenyx HemoGenyx Seres Therapeutics Seres Therapeutics EasySense EasySense CALIXAR CALIXAR Myomo Myomo M.S.T - Medical Surgery Technologies Ltd. M.S.T - Medical Surgery Technologies Ltd. Medigus Medigus Ovid Therapeutics Ovid Therapeutics

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 7
Add info
15 Oct 2014
$20,000,000
Private equity
28 Aug 2014
$4,450,000
Venture capital
17 Jun 2014
$8,100,000
Grant
13 Feb 2012
$22,000,000
Venture capital (Series D)
RUSNANO
17 Aug 2010
$3,000,000
Grant
National Institute on Drug Abuse (NIDA)
05 Apr 2010
$15,000,000
Venture capital (Series C)
Flagship Ventures, Polaris Partners, NanoDimension, +2
25 Feb 2009
$15,100,000
Venture capital (Series B)
Flagship Ventures, Polaris Partners, NanoDimension, +1